Fig. 2.
PINP (A), osteocalcin (OCN) (B), and undercarboxylated OCN (C) levels in the diabetic (open circles, dashed lines) and nondiabetic (closed circles, solid lines) subjects at the end of the low (L), intermediate (I), and high (H) doses. Because the changes in the diabetic and nondiabetic subjects were similar, the squares and dark solid lines indicate the mean values (± sem) in the two groups combined.